Want to see CMND full AI Analyst Report?
Clearmind Medicine (CMND) Income Statement
Clearmind Medicine Income Statement
Last quarter (Q3 2026), Clearmind Medicine's total revenue was $0.00. In Q3, Clearmind Medicine's net income was $-907.29K. See Clearmind Medicine’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Oct 25 | Oct 24 | Oct 23 | Jan 23 | Jan 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -49.36K | $ -51.07K | $ -57.43K | $ -119.62K | $ -2.53K | |
| $ 5.62M | $ 5.69M | $ 6.24M | $ 8.88M | $ 3.61M | |
| Depreciation and Amortization | $ 49.36K | $ 51.07K | $ 57.51K | $ 112.98K | ― |
| $ -3.72M | $ -4.79M | $ -8.53M | $ -9.75M | ― | |
| $ -5.67M | $ -5.74M | $ -6.29M | $ -9.00M | $ -3.61M | |
| $ 1.88M | $ 868.21K | ― | $ -883.54K | $ -42.78K | |
| $ -3.79M | $ -4.88M | $ -8.59M | $ -9.89M | $ -3.66M | |
| $ -3.86M | $ -5.25M | $ -8.61M | $ -9.93M | $ -3.66M | |
| Per Share Metrics | |||||
| Basic EPS | $ -24.24 | $ -54.24 | $ -1360.56 | $ -7331.52 | $ -3784.80 |
| Diluted EPS | $ -24.24 | $ -54.24 | $ -1360.56 | $ -7331.52 | $ -3784.80 |
| Weighted Average Shares Outstanding | 158.87K | 96.88K | 6.33K | 1.35K | 966 |
| Weighted Average Shares Outstanding (Diluted) | 158.87K | 96.88K | 6.33K | 1.35K | 966 |
Currency in CAD